Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)

NCT00900627 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Breast Neoplasms
Breast Cancer

Interventions

DRUG: AZD8931
DRUG: Paclitaxel
DRUG: Placebo

Sponsor

AstraZeneca